Zoltek Companies (Nasdaq: ZOLT) reported earnings on Feb. 1. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q1), Zoltek Companies whiffed on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue dropped significantly and GAAP earnings per share dropped significantly.

Margins shrank across the board.

Revenue details
Zoltek Companies reported revenue of $35.9 million. The three analysts polled by S&P Capital IQ expected to see revenue of $43.0 million on the same basis. GAAP reported sales were 24% lower than the prior-year quarter's $47.0 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.09. The three earnings estimates compiled by S&P Capital IQ predicted $0.13 per share. GAAP EPS of $0.09 for Q1 were 68% lower than the prior-year quarter's $0.28 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 25.3%, 270 basis points worse than the prior-year quarter. Operating margin was 10.2%, 720 basis points worse than the prior-year quarter. Net margin was 8.3%, 1,230 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $39.7 million. On the bottom line, the average EPS estimate is $0.10.

Next year's average estimate for revenue is $171.3 million. The average EPS estimate is $0.50.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 721 members out of 763 rating the stock outperform, and 42 members rating it underperform. Among 158 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 145 give Zoltek Companies a green thumbs-up, and 13 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Zoltek Companies is outperform, with an average price target of $8.50.

Looking for alternatives to Zoltek Companies? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.